EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype

Irina Kramerova, Frieda Anastopulos, Diana Becerra, Ruby Goldstein de Salazar, Alexander R Keeble, Jeffrey S Chamberlain, Steven A Moore, Elizabeth M McNally iD, Melissa J Spencer iD

Human Molecular Genetics · 11.09.2026 · 35 (19)

DOI: 10.1093/hmg/ddag090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 11.09.2026. Verfasst von Irina Kramerova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, David Geffen School of Medicine at UCLA, University of California, 635 Charles E. Young Drive, Los Angeles, CA 90095, United…. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, Muscle, Skeletal, Muscular Dystrophies, Limb-Girdle, Calpain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcium calmodulin kinase II (CaMKII) signaling is activated by muscle use and drives gene expression that promotes slow oxidative muscle phenotype. Previously, we showed that the calpain 3 knockout (C3KO) mouse model of limb girdle muscular dystrophy R1 (LGMDR1) exhibits impaired slow-oxidative gene expression and these deficits were associated with reduced levels of the CaMKIIβ isoform and attenuated CaMKII signaling in C3KO muscles. To investigate the contribution of CaMKIIβ signaling to the calpain 3-deficient phenotype, we generated both loss-of-function (muscle-specific conditional knockout, Camk2b cKO) and gain-of-function (muscle-specific overexpression of a constitutively active CaMK2b) models. Camk2b cKO muscles exhibited myopathic features and weakness and their muscles failed to upregulate genes that promote oxidative metabolism and stress-responses following endurance exercise, similarly to C3KO muscles. Mitochondrial respiration showed reduced activity of complex I, complex II and fatty acid oxidation. RNA sequencing of LGMDR1 patient biopsies revealed a similar reduction in genes involved in oxidative metabolism, aligning human and mouse findings. Overexpression of a constitutively active Camk2b in C3KO muscles enhanced oxidative metabolism and improved functional performance. Our results support the hypothesis that blunted CaMKIIβ signaling contributes to the failed upregulation of genes involved in oxidative metabolism and stress-responses in C3KO muscles. These studies highlight metabolic insufficiency as a central contributor to LGMDR1 pathogenesis and support the therapeutic potential of targeting CaMKII signaling to ameliorate disease features in LGMDR1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium-Calmodulin-Dependent Protein Kinase Type 2Muscle, SkeletalMuscular Dystrophies, Limb-GirdleCalpainAnimalsMiceSignal TransductionMice, KnockoutHumansDisease Models, AnimalPhenotypeGene Expression RegulationOxidative StressMuscle Proteins

Stichwörter der Autor:innen

disease pathwaysgene expressionmouse modelmuscular dystrophy

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 2CalpainCapn3 protein, mouseCamk2b protein, mouseMuscle Proteins

Autor:innen und Institutionen

  • Department of Neurology, David Geffen School of Medicine at UCLA, University of California, 635 Charles E. Young Drive, Los Angeles, CA 90095, United States.
  • Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, 303 E. Superior St, SQ 5-516 Chicago IL 60611, United States.
  • University of Washington, 850 Republican Street, Seattle WA 98109, United States.
  • Department of Pathology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, United States.
  • Molecular Biology Institute, University of California, 611 Charles E. Young Dr., Los Angeles, CA 90095, United States.
  • Jonsson Comprehensive Cancer Center, University of California, 10833 Le Conte Ave, Los Angeles, CA 90024, United States.

ORCID-Profile: Elizabeth M McNally, Melissa J Spencer

Förderung

  • NIAMS NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Kramerova, I., Anastopulos, F., Becerra, D., Goldstein de Salazar, R., Keeble, A. R., Chamberlain, J. S., Moore, S. A., McNally, E. M., & Spencer, M. J. (2026). CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype. Human Molecular Genetics, 35(19). https://doi.org/10.1093/hmg/ddag090

Vancouver

Kramerova I, Anastopulos F, Becerra D, Goldstein de Salazar R, Keeble AR, Chamberlain JS, et al. CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype. Human Molecular Genetics. 2026;35(19). doi:10.1093/hmg/ddag090

BibTeX
@article{Kramerova2026,
  author = {Kramerova, Irina and Anastopulos, Frieda and Becerra, Diana and Goldstein de Salazar, Ruby and Keeble, Alexander R and Chamberlain, Jeffrey S and Moore, Steven A and McNally, Elizabeth M and Spencer, Melissa J},
  title = {CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype},
  journal = {Human Molecular Genetics},
  year = {2026},
  volume = {35},
  number = {19},
  doi = {10.1093/hmg/ddag090}
}
Kostenlos starten →